Allarity Therapeutics, Inc. (ALLR)
NASDAQ: ALLR · Real-Time Price · USD
1.160
+0.030 (2.65%)
At close: Apr 2, 2026, 4:00 PM EDT
1.140
-0.020 (-1.72%)
After-hours: Apr 2, 2026, 6:49 PM EDT
Allarity Therapeutics Market Cap
Allarity Therapeutics has a market cap or net worth of $18.65 million as of April 2, 2026. Its market cap has increased by 320.74% in one year.
Market Cap
18.65M
Enterprise Value
5.37M
1-Year Change
320.74%
Ranking
Category
Stock Price
$1.16
Market Cap Chart
Since December 21, 2021, Allarity Therapeutics's market cap has decreased from $79.38M to $18.65M, a decrease of -76.50%. That is a compound annual growth rate of -28.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 18.65M | 9.30% |
| Dec 31, 2025 | 17.07M | 229.00% |
| Dec 31, 2024 | 5.19M | 106.50% |
| Dec 29, 2023 | 2.51M | -40.12% |
| Dec 30, 2022 | 4.20M | -94.65% |
| Dec 31, 2021 | 78.43M | -1.20% |
| Dec 21, 2021 | 79.38M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lexaria Bioscience | 21.56M |
| Curis | 21.31M |
| NanoViricides | 20.61M |
| Polyrizon | 20.46M |
| VYNE Therapeutics | 20.19M |
| Cue Biopharma | 19.79M |
| Citius Pharmaceuticals | 18.87M |
| Tevogen Bio Holdings | 18.66M |